{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T10:45:19Z","timestamp":1788777919569,"version":"build-2803163510"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T00:00:00Z","timestamp":1593734400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006696","name":"Fondazione Guido Berlucchi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006696","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2020.00994","type":"journal-article","created":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T08:03:07Z","timestamp":1593763387000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":23,"title":["Insulin-Like Growth Factor 2 mRNA-Binding Protein 3 Modulates Aggressiveness of Ewing Sarcoma by Regulating the CD164-CXCR4 Axis"],"prefix":"10.3389","volume":"10","author":[{"given":"Caterina","family":"Mancarella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Caldoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Ribolsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Parra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Cristina","family":"Manara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur M.","family":"Mercurio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Morrione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katia","family":"Scotlandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,7,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3036","DOI":"10.1200\/JCO.2014.59.5256","article-title":"Ewing sarcoma: current management and future approaches through collaboration","volume":"33","author":"Gaspar","year":"2015","journal-title":"J Clin Oncol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41572-018-0003-x","article-title":"Ewing sarcoma","volume":"4","author":"Grunewald","year":"2018","journal-title":"Nat Rev Dis Primers."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gene.2005.08.007","article-title":"EWS-ETS oncoproteins: the linchpins of Ewing tumors","volume":"363","author":"Janknecht","year":"2005","journal-title":"Gene."},{"key":"B4","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1615\/CritRevOncog.2015013553","article-title":"Twenty years on: what do we really know about Ewing sarcoma and what is the path forward?","volume":"20","author":"Lawlor","year":"2015","journal-title":"Crit Rev Oncog."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.neo.2019.08.007","article-title":"Microenvironmental factors drive Tenascin C and src cooperation to promote invadopodia formation in Ewing sarcoma","volume":"21","author":"Hawkins","year":"2019","journal-title":"Neoplasia."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e1004475","DOI":"10.1371\/journal.pgen.1004475","article-title":"The genomic landscape of the Ewing Sarcoma family of tumors reveals recurrent STAG2 mutation","volume":"10","author":"Brohl","year":"2014","journal-title":"PLoS Genet."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1158\/2159-8290.CD-13-1037","article-title":"The genomic landscape of pediatric Ewing sarcoma","volume":"4","author":"Crompton","year":"2014","journal-title":"Cancer Discov."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1158\/2159-8290.CD-14-0622","article-title":"Genomic landscape of Ewing sarcoma defines an aggressive subtype with co-association of STAG2 and TP53 mutations","volume":"4","author":"Tirode","year":"2014","journal-title":"Cancer Discov."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1200\/JCO.2008.19.2542","article-title":"Overcoming resistance to conventional drugs in Ewing sarcoma and identification of molecular predictors of outcome","volume":"27","author":"Scotlandi","year":"2009","journal-title":"J Clin Oncol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.ccell.2014.10.004","article-title":"EWS-FLI1 utilizes divergent chromatin remodeling mechanisms to directly activate or repress enhancer elements in Ewing sarcoma","volume":"26","author":"Riggi","year":"2014","journal-title":"Cancer Cell."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/j.celrep.2015.01.042","article-title":"Epigenome mapping reveals distinct modes of gene regulation and widespread enhancer reprogramming by the oncogenic fusion protein EWS-FLI1","volume":"10","author":"Tomazou","year":"2015","journal-title":"Cell Rep."},{"key":"B12","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/nm.4273","article-title":"DNA methylation heterogeneity defines a disease spectrum in Ewing sarcoma","volume":"23","author":"Sheffield","year":"2017","journal-title":"Nat Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1158\/1541-7786.MCR-13-0668","article-title":"Stress-induced CXCR4 promotes migration and invasion of Ewing sarcoma","volume":"12","author":"Krook","year":"2014","journal-title":"Mol Cancer Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.neo.2016.06.008","article-title":"Micro-environmental stress induces Src-dependent activation of invadopodia and cell migration in Ewing sarcoma","volume":"18","author":"Bailey","year":"2016","journal-title":"Neoplasia."},{"key":"B15","doi-asserted-by":"publisher","first-page":"61775","DOI":"10.18632\/oncotarget.11240","article-title":"A bivalent promoter contributes to stress-induced plasticity of CXCR4 in Ewing sarcoma","volume":"7","author":"Krook","year":"2016","journal-title":"Oncotarget."},{"key":"B16","doi-asserted-by":"publisher","first-page":"5995","DOI":"10.1038\/onc.2017.202","article-title":"EWS-FLI1 perturbs MRTFB\/YAP-1\/TEAD target gene regulation inhibiting cytoskeletal autoregulatory feedback in Ewing sarcoma","volume":"36","author":"Katschnig","year":"2017","journal-title":"Oncogene."},{"key":"B17","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.ccell.2015.04.003","article-title":"Translational activation of HIF1\u03b1 by YB-1 promotes sarcoma metastasis","volume":"27","author":"El-Naggar","year":"2015","journal-title":"Cancer Cell."},{"key":"B18","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1083\/jcb.201411047","article-title":"YB-1 regulates stress granule formation and tumor progression by translationally activating G3BP1","volume":"208","author":"Somasekharan","year":"2015","journal-title":"J Cell Biol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"650","DOI":"10.3390\/ijms19030650","article-title":"Messenger RNA life-cycle in cancer cells: emerging role of conventional and non-conventional RNA-binding proteins?","volume":"19","author":"Coppin","year":"2018","journal-title":"Int J Mol Sci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"178","DOI":"10.3389\/fendo.2018.00178","article-title":"Insulin-like growth factor 2 mRNA-binding protein 3 influences sensitivity to anti-IGF system agents through the translational regulation of IGF1R.","volume":"9","author":"Mancarella","year":"2018","journal-title":"Front Endocrinol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"3704","DOI":"10.1158\/1078-0432.CCR-17-2602","article-title":"Insulin-like growth factor 2 mRNA-binding protein 3 is a novel post-transcriptional regulator of Ewing sarcoma malignancy","volume":"24","author":"Mancarella","year":"2018","journal-title":"Clin Cancer Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1101\/gad.287540.116","article-title":"IMPs: an RNA-binding protein family that provides a link between stem cell maintenance in normal development and cancer","volume":"30","author":"Degrauwe","year":"2016","journal-title":"Genes Dev."},{"key":"B23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.semcancer.2014.07.006","article-title":"The role of the oncofetal IGF2 mRNA-binding protein 3 (IGF2BP3) in cancer","volume":"29","author":"Lederer","year":"2014","journal-title":"Semin Cancer Biol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s00428-019-02720-8","article-title":"Ewing sarcoma and Ewing-like tumors","volume":"476","author":"Sbaraglia","year":"2019","journal-title":"Virchows Arch."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1016\/S0959-8049(02)00148-X","article-title":"Neoadjuvant chemotherapy for Ewing's tumour of bone: recent experience at the Rizzoli Orthopaedic Institute","volume":"38","author":"Bacci","year":"2002","journal-title":"Eur J Cancer."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1093\/annonc\/mdq573","article-title":"Nonmetastatic Ewing family tumors: high-dose chemotherapy with stem cell rescue in poor responder patients. Results of the Italian Sarcoma Group\/Scandinavian Sarcoma Group III protocol.","volume":"22","author":"Ferrari","year":"2011","journal-title":"Ann Oncol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1200\/JCO.1997.15.4.1553","article-title":"Chemotherapy-induced tumor necrosis as a prognostic factor in localized Ewing's sarcoma of the extremities","volume":"15","author":"Picci","year":"1997","journal-title":"J Clin Oncol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1172\/JCI36667","article-title":"CD99 inhibits neural differentiation of human Ewing sarcoma cells and thereby contributes to oncogenesis","volume":"120","author":"Rocchi","year":"2010","journal-title":"J Clin Invest."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1210\/me.2012-1142","article-title":"Identification of common and distinctive mechanisms of resistance to different anti-IGF-IR agents in Ewing's sarcoma","volume":"26","author":"Garofalo","year":"2012","journal-title":"Mol Endocrinol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2[\u2212DeltaDeltaC(T)] Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods."},{"key":"B31","doi-asserted-by":"publisher","first-page":"79925","DOI":"10.18632\/oncotarget.13160","article-title":"CD99 triggering induces methuosis of Ewing sarcoma cells through IGF-1R\/RAS\/Rac1 signaling","volume":"7","author":"Manara","year":"2016","journal-title":"Oncotarget."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1213\/ANE.0000000000002864","article-title":"Correlation coefficients: appropriate use and interpretation","volume":"126","author":"Schober","year":"2018","journal-title":"Anesth Analg."},{"key":"B33","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.cell.2010.03.009","article-title":"Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP.","volume":"141","author":"Hafner","year":"2010","journal-title":"Cell."},{"key":"B34","doi-asserted-by":"publisher","first-page":"4689","DOI":"10.1038\/onc.2011.620","article-title":"Regulation of IMP3 by EGFR signaling and repression by ERbeta: implications for triple-negative breast cancer","volume":"31","author":"Samanta","year":"2012","journal-title":"Oncogene."},{"key":"B35","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/1471-2407-6-195","article-title":"The role of sialomucin CD164 (MGC-24v or endolyn) in prostate cancer metastasis","volume":"6","author":"Havens","year":"2006","journal-title":"BMC Cancer."},{"key":"B36","doi-asserted-by":"publisher","first-page":"380","DOI":"10.3109\/07357907.2012.666692","article-title":"Inhibiting CD164 expression in colon cancer cell line HCT116 leads to reduced cancer cell proliferation, mobility, and metastasis in vitro and in vivo","volume":"30","author":"Tang","year":"2012","journal-title":"Cancer Invest."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1182\/blood-2006-05-023028","article-title":"Endolyn (CD164) modulates the CXCL12-mediated migration of umbilical cord blood CD133+ cells","volume":"109","author":"Forde","year":"2007","journal-title":"Blood."},{"key":"B38","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/1476-4598-12-115","article-title":"CD164 regulates the tumorigenesis of ovarian surface epithelial cells through the SDF-1\u03b1\/CXCR4 axis","volume":"12","author":"Huang","year":"2013","journal-title":"Mol Cancer."},{"key":"B39","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12964-015-0102-1","article-title":"Dynasore\u2013not just a dynamin inhibitor","volume":"13","author":"Preta","year":"2015","journal-title":"Cell Commun Signal."},{"key":"B40","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1146\/annurev-pathol-012513-104720","article-title":"Oxygen sensing, hypoxia-inducible factors, and disease pathophysiology","volume":"9","author":"Semenza","year":"2014","journal-title":"Annu Rev Pathol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.1016\/j.ejca.2015.08.020","article-title":"CXCL14, CXCR7 expression and CXCR4 splice variant ratio associate with survival and metastases in Ewing sarcoma patients","volume":"51","author":"Sand","year":"2015","journal-title":"Eur J Cancer."},{"key":"B42","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1111\/boc.201300041","article-title":"The Zyxin-related protein thyroid receptor interacting protein 6 (TRIP6) is overexpressed in Ewing's sarcoma and promotes migration, invasion and cell growth","volume":"105","author":"Grunewald","year":"2013","journal-title":"Biol Cell."},{"key":"B43","doi-asserted-by":"publisher","first-page":"6","DOI":"10.13188\/2381-3326.1000006","article-title":"MicroRNA-124 suppresses tumor cell proliferation and invasion by targeting CD164 signaling pathway in non-small cell lung cancer","volume":"2","author":"Lin","year":"2016","journal-title":"J Gene Ther."},{"key":"B44","doi-asserted-by":"publisher","first-page":"10274","DOI":"10.18632\/oncotarget.14394","article-title":"miR-124 represses the mesenchymal features and suppresses metastasis in Ewing sarcoma","volume":"8","author":"Li","year":"2017","journal-title":"Oncotarget."},{"key":"B45","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.celrep.2015.06.059","article-title":"CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal-transition-like transcriptional activation","volume":"12","author":"Roccaro","year":"2015","journal-title":"Cell Rep."},{"key":"B46","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s10585-013-9632-3","article-title":"CXCR4 antibody treatment suppresses metastatic spread to the lung of intratibial human osteosarcoma xenografts in mice","volume":"31","author":"Brennecke","year":"2014","journal-title":"Clin Exp Metastasis."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1111\/cas.12490","article-title":"Inhibition of metastasis of rhabdomyosarcoma by a novel neutralizing antibody to CXC chemokine receptor-4","volume":"105","author":"Kashima","year":"2014","journal-title":"Cancer Sci."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.3389\/fimmu.2019.01814","article-title":"Anti-CXCR4 antibody combined with activated and expanded Natural Killer cells for sarcoma immunotherapy","volume":"10","author":"Vela","year":"2019","journal-title":"Front Immunol."},{"key":"B49","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/nar\/30.1.207","article-title":"Gene Expression Omnibus: NCBI gene expression and hybridization array data repository","volume":"30","author":"Edgar","year":"2002","journal-title":"Nucleic Acids Res."}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2020.00994\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T08:03:11Z","timestamp":1593763391000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2020.00994\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,3]]},"references-count":49,"alternative-id":["10.3389\/fonc.2020.00994"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2020.00994","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,3]]},"article-number":"994"}}